Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Active, Not Recruiting

A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy

NCT03520491

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All protocol activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma

NCT04919122

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • State University of Iowa Iowa City, Iowa, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Ochsner Clinic Foundation d/b/a Ochsner Health New Orleans, Louisiana, United States
  • The Johns Hopkins University Baltimore, Maryland, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

NCT05863052

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +46 more
Locations
  • Arizona Cancer Center at the Unvieristy of Arizona Tucson, Arizona, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Monument Health Cancer Care Institute Rapid City, South Dakota, United States
View Trial Details
Active, Not Recruiting

Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors

NCT05479812

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +37 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Northwestern University Chicago, Illinois, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

NCT05239143

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +66 more
Locations
  • University of California, Irvine Medical Center Irvine, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study)

NCT03203473

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +9 more
Locations
  • University of California, San Diego Moores Cancer Center La Jolla, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer

NCT03193528

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of Rochester Medical Center Rochester, New York, United States
  • UT Southwestern Medical Center at Dallas Dallas, Texas, United States
View Trial Details

Related conditions